author_facet Liesman, Rachael M.
Strasburg, Angela P.
Heitman, Angela K.
Theel, Elitza S.
Patel, Robin
Binnicker, Matthew J.
Liesman, Rachael M.
Strasburg, Angela P.
Heitman, Angela K.
Theel, Elitza S.
Patel, Robin
Binnicker, Matthew J.
author Liesman, Rachael M.
Strasburg, Angela P.
Heitman, Angela K.
Theel, Elitza S.
Patel, Robin
Binnicker, Matthew J.
spellingShingle Liesman, Rachael M.
Strasburg, Angela P.
Heitman, Angela K.
Theel, Elitza S.
Patel, Robin
Binnicker, Matthew J.
Journal of Clinical Microbiology
Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
Microbiology (medical)
author_sort liesman, rachael m.
spelling Liesman, Rachael M. Strasburg, Angela P. Heitman, Angela K. Theel, Elitza S. Patel, Robin Binnicker, Matthew J. 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.01927-17 <jats:title>ABSTRACT</jats:title> <jats:p> Rapid and accurate laboratory tests are important for the timely diagnosis and treatment of central nervous system infections. The FilmArray meningitis/encephalitis (ME) panel (BioFire Diagnostics, Salt Lake City, UT) is an FDA-cleared, multiplex molecular panel that allows the detection of 14 pathogens (bacterial [ <jats:italic>n</jats:italic> = 6], viral [ <jats:italic>n</jats:italic> = 7], and fungal [ <jats:italic>n</jats:italic> = 1] pathogens) from cerebrospinal fluid (CSF). In this study, we evaluated the performance characteristics of the FilmArray ME panel using clinical, residual CSF samples ( <jats:italic>n</jats:italic> = 291) that tested positive by a routine method(s) (e.g., bacterial culture, individual real-time PCR assay) for a pathogen represented on the ME panel. Of note, a subset ( <jats:italic>n</jats:italic> = 76) of the CSF specimens was collected during the prevaccine era and had been characterized as positive for a bacterial pathogen. The FilmArray ME panel demonstrated an overall percent positive agreement (PPA) of 97.5% (78/80) for bacterial pathogens, 90.1% (145/161) for viruses, and 52% (26/50) for <jats:named-content content-type="genus-species">Cryptococcus</jats:named-content> <jats:italic>neoformans/C. gattii</jats:italic> . Despite the low overall agreement (52%) between the ME panel and antigen testing for detection of <jats:italic>C. neoformans/C. gattii</jats:italic> , the percent positive agreement of the FilmArray assay for <jats:italic>C. neoformans/C. gattii</jats:italic> was 92.3% (12/13) when the results were compared directly to the results of routine fungal smear or culture. The FilmArray ME panel offers a rapid (∼60-min), syndrome-based approach for the detection of select meningitis and encephalitis pathogens. </jats:p> Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis Journal of Clinical Microbiology
doi_str_mv 10.1128/jcm.01927-17
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMDE5MjctMTc
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMDE5MjctMTc
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Society for Microbiology, 2018
imprint_str_mv American Society for Microbiology, 2018
issn 0095-1137
1098-660X
issn_str_mv 0095-1137
1098-660X
language English
mega_collection American Society for Microbiology (CrossRef)
match_str liesman2018evaluationofacommercialmultiplexmolecularpanelfordiagnosisofinfectiousmeningitisandencephalitis
publishDateSort 2018
publisher American Society for Microbiology
recordtype ai
record_format ai
series Journal of Clinical Microbiology
source_id 49
title Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_unstemmed Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_full Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_fullStr Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_full_unstemmed Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_short Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_sort evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.01927-17
publishDate 2018
physical
description <jats:title>ABSTRACT</jats:title> <jats:p> Rapid and accurate laboratory tests are important for the timely diagnosis and treatment of central nervous system infections. The FilmArray meningitis/encephalitis (ME) panel (BioFire Diagnostics, Salt Lake City, UT) is an FDA-cleared, multiplex molecular panel that allows the detection of 14 pathogens (bacterial [ <jats:italic>n</jats:italic> = 6], viral [ <jats:italic>n</jats:italic> = 7], and fungal [ <jats:italic>n</jats:italic> = 1] pathogens) from cerebrospinal fluid (CSF). In this study, we evaluated the performance characteristics of the FilmArray ME panel using clinical, residual CSF samples ( <jats:italic>n</jats:italic> = 291) that tested positive by a routine method(s) (e.g., bacterial culture, individual real-time PCR assay) for a pathogen represented on the ME panel. Of note, a subset ( <jats:italic>n</jats:italic> = 76) of the CSF specimens was collected during the prevaccine era and had been characterized as positive for a bacterial pathogen. The FilmArray ME panel demonstrated an overall percent positive agreement (PPA) of 97.5% (78/80) for bacterial pathogens, 90.1% (145/161) for viruses, and 52% (26/50) for <jats:named-content content-type="genus-species">Cryptococcus</jats:named-content> <jats:italic>neoformans/C. gattii</jats:italic> . Despite the low overall agreement (52%) between the ME panel and antigen testing for detection of <jats:italic>C. neoformans/C. gattii</jats:italic> , the percent positive agreement of the FilmArray assay for <jats:italic>C. neoformans/C. gattii</jats:italic> was 92.3% (12/13) when the results were compared directly to the results of routine fungal smear or culture. The FilmArray ME panel offers a rapid (∼60-min), syndrome-based approach for the detection of select meningitis and encephalitis pathogens. </jats:p>
container_issue 4
container_start_page 0
container_title Journal of Clinical Microbiology
container_volume 56
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792346199360012290
geogr_code not assigned
last_indexed 2024-03-01T17:35:35.674Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Evaluation+of+a+Commercial+Multiplex+Molecular+Panel+for+Diagnosis+of+Infectious+Meningitis+and+Encephalitis&rft.date=2018-04-01&genre=article&issn=1098-660X&volume=56&issue=4&jtitle=Journal+of+Clinical+Microbiology&atitle=Evaluation+of+a+Commercial+Multiplex+Molecular+Panel+for+Diagnosis+of+Infectious+Meningitis+and+Encephalitis&aulast=Binnicker&aufirst=Matthew+J.&rft_id=info%3Adoi%2F10.1128%2Fjcm.01927-17&rft.language%5B0%5D=eng
SOLR
_version_ 1792346199360012290
author Liesman, Rachael M., Strasburg, Angela P., Heitman, Angela K., Theel, Elitza S., Patel, Robin, Binnicker, Matthew J.
author_facet Liesman, Rachael M., Strasburg, Angela P., Heitman, Angela K., Theel, Elitza S., Patel, Robin, Binnicker, Matthew J., Liesman, Rachael M., Strasburg, Angela P., Heitman, Angela K., Theel, Elitza S., Patel, Robin, Binnicker, Matthew J.
author_sort liesman, rachael m.
container_issue 4
container_start_page 0
container_title Journal of Clinical Microbiology
container_volume 56
description <jats:title>ABSTRACT</jats:title> <jats:p> Rapid and accurate laboratory tests are important for the timely diagnosis and treatment of central nervous system infections. The FilmArray meningitis/encephalitis (ME) panel (BioFire Diagnostics, Salt Lake City, UT) is an FDA-cleared, multiplex molecular panel that allows the detection of 14 pathogens (bacterial [ <jats:italic>n</jats:italic> = 6], viral [ <jats:italic>n</jats:italic> = 7], and fungal [ <jats:italic>n</jats:italic> = 1] pathogens) from cerebrospinal fluid (CSF). In this study, we evaluated the performance characteristics of the FilmArray ME panel using clinical, residual CSF samples ( <jats:italic>n</jats:italic> = 291) that tested positive by a routine method(s) (e.g., bacterial culture, individual real-time PCR assay) for a pathogen represented on the ME panel. Of note, a subset ( <jats:italic>n</jats:italic> = 76) of the CSF specimens was collected during the prevaccine era and had been characterized as positive for a bacterial pathogen. The FilmArray ME panel demonstrated an overall percent positive agreement (PPA) of 97.5% (78/80) for bacterial pathogens, 90.1% (145/161) for viruses, and 52% (26/50) for <jats:named-content content-type="genus-species">Cryptococcus</jats:named-content> <jats:italic>neoformans/C. gattii</jats:italic> . Despite the low overall agreement (52%) between the ME panel and antigen testing for detection of <jats:italic>C. neoformans/C. gattii</jats:italic> , the percent positive agreement of the FilmArray assay for <jats:italic>C. neoformans/C. gattii</jats:italic> was 92.3% (12/13) when the results were compared directly to the results of routine fungal smear or culture. The FilmArray ME panel offers a rapid (∼60-min), syndrome-based approach for the detection of select meningitis and encephalitis pathogens. </jats:p>
doi_str_mv 10.1128/jcm.01927-17
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMDE5MjctMTc
imprint American Society for Microbiology, 2018
imprint_str_mv American Society for Microbiology, 2018
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0095-1137, 1098-660X
issn_str_mv 0095-1137, 1098-660X
language English
last_indexed 2024-03-01T17:35:35.674Z
match_str liesman2018evaluationofacommercialmultiplexmolecularpanelfordiagnosisofinfectiousmeningitisandencephalitis
mega_collection American Society for Microbiology (CrossRef)
physical
publishDate 2018
publishDateSort 2018
publisher American Society for Microbiology
record_format ai
recordtype ai
series Journal of Clinical Microbiology
source_id 49
spelling Liesman, Rachael M. Strasburg, Angela P. Heitman, Angela K. Theel, Elitza S. Patel, Robin Binnicker, Matthew J. 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.01927-17 <jats:title>ABSTRACT</jats:title> <jats:p> Rapid and accurate laboratory tests are important for the timely diagnosis and treatment of central nervous system infections. The FilmArray meningitis/encephalitis (ME) panel (BioFire Diagnostics, Salt Lake City, UT) is an FDA-cleared, multiplex molecular panel that allows the detection of 14 pathogens (bacterial [ <jats:italic>n</jats:italic> = 6], viral [ <jats:italic>n</jats:italic> = 7], and fungal [ <jats:italic>n</jats:italic> = 1] pathogens) from cerebrospinal fluid (CSF). In this study, we evaluated the performance characteristics of the FilmArray ME panel using clinical, residual CSF samples ( <jats:italic>n</jats:italic> = 291) that tested positive by a routine method(s) (e.g., bacterial culture, individual real-time PCR assay) for a pathogen represented on the ME panel. Of note, a subset ( <jats:italic>n</jats:italic> = 76) of the CSF specimens was collected during the prevaccine era and had been characterized as positive for a bacterial pathogen. The FilmArray ME panel demonstrated an overall percent positive agreement (PPA) of 97.5% (78/80) for bacterial pathogens, 90.1% (145/161) for viruses, and 52% (26/50) for <jats:named-content content-type="genus-species">Cryptococcus</jats:named-content> <jats:italic>neoformans/C. gattii</jats:italic> . Despite the low overall agreement (52%) between the ME panel and antigen testing for detection of <jats:italic>C. neoformans/C. gattii</jats:italic> , the percent positive agreement of the FilmArray assay for <jats:italic>C. neoformans/C. gattii</jats:italic> was 92.3% (12/13) when the results were compared directly to the results of routine fungal smear or culture. The FilmArray ME panel offers a rapid (∼60-min), syndrome-based approach for the detection of select meningitis and encephalitis pathogens. </jats:p> Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis Journal of Clinical Microbiology
spellingShingle Liesman, Rachael M., Strasburg, Angela P., Heitman, Angela K., Theel, Elitza S., Patel, Robin, Binnicker, Matthew J., Journal of Clinical Microbiology, Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis, Microbiology (medical)
title Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_full Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_fullStr Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_full_unstemmed Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_short Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
title_sort evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis
title_unstemmed Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.01927-17